Skip to Content
Merck
CN

L8039

Lipoprotein, high density from human plasma

≥95% (SDS-PAGE), solution

Synonym(s):

α-Lipoprotein, HDL, High density lipoprotein

Sign In to View Organizational & Contract Pricing.

Select a Size

About This Item

CAS Number:
308068-14-6
UNSPSC Code:
12352211
NACRES:
NA.25
MDL number:
MFCD00164407

Key Documents

View All Documentation
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Product Name

Lipoprotein, high density from human plasma, ≥95% (SDS-PAGE), solution

biological source

human plasma

assay

≥95% (SDS-PAGE)

form

solution

packaging

vial of 10 mg protein

technique(s)

cell culture | mammalian: suitable

UniProt accession no.

P02649
P02655
P04114

functional group

ester
phospholipid

shipped in

wet ice

storage temp.

2-8°C

Quality Level

200

Gene Information

human ... APOB(338), APOC2(344), APOE(348)

Looking for similar products? Visit Product Comparison Guide

Related Categories

Biochem/physiol Actions

High density lipoprotein (HDL) serves as the transit agent for cholesterol away from blood, tissues, and organs of the body to the liver, where cholesterol breakdown occurs. This process ultimately helps to remove cholesterol from the arteries. Colloquially known as the "good cholesterol", HDL makes up 20%-30% of the total cholesterol in the body.

HDL is used in cardiovascular research and the development of potential therapeutic approaches to cardiovascular risk management.

Disclaimer

RESEARCH USE ONLY. This product is regulated in France when intended to be used for scientific purposes, including for import and export activities (Article L 1211-1 paragraph 2 of the Public Health Code). The purchaser (i.e. enduser) is required to obtain an import authorization from the France Ministry of Research referred in the Article L1245-5-1 II. of Public Health Code. By ordering this product, you are confirming that you have obtained the proper import authorization.

Other Notes

View more information on lipoprotein function and lipid transport at www.sigma-aldrich.com/enzymeexplorer

Physical form

Solution in 150 mM NaCl and 0.01% EDTA, pH 7.4.

Storage Class

10 - Combustible liquids

wgk

WGK 2

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, multi-purpose combination respirator cartridge (US)

Regulatory Information

高风险级别生物产品--人源产品
This item has

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
0000497648
0000497648
0000338721
0000338721
0000293205

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Tisha R Joy
Pharmacology & therapeutics, 135(1), 18-30 (2012-04-03)
Reduction in low-density lipoprotein cholesterol (LDL-C) levels has been associated with a 25-30% reduction in cardiovascular disease risk. However, there still remains a significant and quantifiable risk. Since epidemiologic data have demonstrated that low levels of high-density lipoprotein cholesterol (HDL-C)
Kyung-Hyun Cho
Medicines (Basel, Switzerland), 8(7) (2021-08-07)
The composition and properties of apolipoprotein (apo) A-I and apoA-II in high-density lipoproteins (HDL) might be critical to SARS-CoV-2 infection via SR-BI and antiviral activity against COVID-19. HDL containing native apoA-I showed potent antiviral activity, while HDL containing glycated apoA-I
Mark J Cziraky et al.
Journal of managed care pharmacy : JMCP, 14(8 Suppl), S3-28 (2009-11-07)
Most clinicians recognize the importance of reducing low-density lipoprotein cholesterol (LDL-C) and, therefore, address this therapeutic need to decrease cardiovascular disease risk. In addition to the critical role that LDL-C plays, recent studies have shown the contribution of other lipid
Santiago Redondo et al.
Lipids in health and disease, 10, 175-175 (2011-10-12)
Epidemiologic studies indicate a strong inverse correlation between plasma levels of high-density lipoproteins (HDL) and cardiovascular disease (CVD). The most relevant cardioprotective mechanism mediated by HDL is thought to be reverse cholesterol transport (RCT). New insights in HDL biology and
Joseph B Dubé et al.
Current opinion in lipidology, 23(2), 133-140 (2012-02-14)
Lipoprotein(a) [Lp(a)] is a risk factor for cardiovascular disease; we highlight the most recent research initiatives that have sought to define Lp(a)-dependent pathogenicity as well as pharmacologic approaches to lowering Lp(a). Recent large-scale meta-analyses have confirmed elevated Lp(a) concentrations to
View All Related Papers

Articles

Cholesterol Transport

Lipoproteins package cholesterol for transport in plasma, essential for lipid transport and cellular function in the body.

Cholesterol Transport

Lipoproteins package cholesterol for transport in plasma, essential for lipid transport and cellular function in the body.

胆固醇的运输

由于胆固醇是水不溶性分子，必须包装后才能在血浆中运输。包装胆固醇、胆固醇酯和甘油三酯以便运输的颗粒称为脂蛋白。

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service